Pediatrix Medical Group, Inc. financial data

Symbol
MD on NYSE
Location
1301 Concord Terrace, Sunrise, FL
State of incorporation
FL
Fiscal year end
December 31
Former names
MEDNAX, INC. (to 6/21/2022)
Latest financial report
10-Q - Q3 2024 - Nov 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 142 % +18.2%
Debt-to-equity 169 % +12.3%
Return On Equity -32.3 % -420%
Return On Assets -12 % -398%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 85.9M shares +2.21%
Common Stock, Shares, Outstanding 85.9M shares +2.31%
Entity Public Float 1.18B USD -5.31%
Common Stock, Value, Issued 859K USD +2.38%
Weighted Average Number of Shares Outstanding, Basic 83.9M shares +1.63%
Weighted Average Number of Shares Outstanding, Diluted 84.5M shares +1.9%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 228M USD +1.07%
Operating Income (Loss) -219M USD -242%
Nonoperating Income (Expense) -54M USD -47.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -274M USD -331%
Income Tax Expense (Benefit) -19.7M USD -165%
Net Income (Loss) Attributable to Parent -254M USD -371%
Earnings Per Share, Basic -1.6 USD/shares -243%
Earnings Per Share, Diluted -1.6 USD/shares -243%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 104M USD +390%
Accounts Receivable, after Allowance for Credit Loss, Current 287M USD +3.44%
Other Assets, Current 9.48M USD +20.5%
Assets, Current 528M USD +25.6%
Deferred Income Tax Assets, Net 119M USD +16.3%
Property, Plant and Equipment, Net 41.9M USD -44.2%
Operating Lease, Right-of-Use Asset 61.7M USD +10.6%
Goodwill 1.24B USD -19.1%
Other Assets, Noncurrent 78.6M USD -27.2%
Assets 2.08B USD -10.7%
Accounts Payable, Current 47.4M USD +49.4%
Liabilities, Current 373M USD +6.46%
Long-term Debt and Lease Obligation 618M USD -2.21%
Deferred Income Tax Liabilities, Net 35.6M USD -13.2%
Operating Lease, Liability, Noncurrent 39.9M USD -17.6%
Other Liabilities, Noncurrent 33M USD +5.92%
Liabilities 1.34B USD -1.03%
Accumulated Other Comprehensive Income (Loss), Net of Tax -209K USD +94.1%
Retained Earnings (Accumulated Deficit) -279M USD -1008%
Stockholders' Equity Attributable to Parent 732M USD -24.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 732M USD -24.3%
Liabilities and Equity 2.08B USD -10.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -125M USD -24.1%
Net Cash Provided by (Used in) Financing Activities 76.2M USD -29.8%
Net Cash Provided by (Used in) Investing Activities -16.2M USD -43.1%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 85.9M shares +2.31%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -65.3M USD -1664%
Deferred Tax Assets, Valuation Allowance 436M USD +1.56%
Deferred Tax Assets, Gross 686M USD -1.45%
Operating Lease, Liability 68.3M USD +3.82%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -251M USD -366%
Lessee, Operating Lease, Liability, to be Paid 76.5M USD +8.27%
Property, Plant and Equipment, Gross 218M USD -11.1%
Operating Lease, Liability, Current 17M USD -22.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 17.4M USD -9.46%
Lessee, Operating Lease, Liability, to be Paid, Year One 22.1M USD +0.67%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +21.7%
Deferred Income Tax Expense (Benefit) 686K USD -65.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.23M USD +68%
Lessee, Operating Lease, Liability, to be Paid, Year Three 12.4M USD +2.25%
Deferred Tax Assets, Operating Loss Carryforwards 34.7M USD +20.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 2.45M USD -13.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.91M USD +16.7%
Depreciation, Depletion and Amortization 34.4M USD -5.05%
Deferred Tax Assets, Net of Valuation Allowance 251M USD -6.27%
Share-based Payment Arrangement, Expense 8.7M USD -31%
Interest Expense 41.4M USD +0.67%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%